Subscribe to all NEOVACS financial information by registering here.

2019/12/09 6:00PM
OPENING OF A CALL FOR TENDER TO PROVIDE A CONTINUATION OR SALE PLAN IN THE FRAME OF REOGANIZATION PROCEEDINGS
Download
2019/11/14 6:00PM
NEOVACS REQUESTS A REORGANIZATION PROCEEDINGS OF THE COMPANY
Download
2019/10/03 6:00PM
NEOVACS ANNOUNCES ITS 2019 HALF-YEAR RESULTS
Download
2019/09/09 6:00PM
2019 Financial Calendar
Download
2019/06/27 6:00PM
NEOVACS ANNOUNCES THE APPOINTMENT of Dr. VIRGINIA PASCUAL AS MEDICAL AND SCIENTIFIC ADVISOR
Download
2019/06/05 6:00PM
NEOVACS TO PRESENT THE PRE-CLINICAL RESULTS OF ITS IFN? KINOID TO TREAT TYPE 1 DIABETES AT THE AMERICAN DIABETES ASSOCIATION'S 79TH SCIENTIFIC SESSIONS (ADA)
Download
2019/05/24 6:00PM
NEOVACS TO PRESENT THE PRE-CLINICAL RESULTS OF ITS THERAPEUTIC VACCINE CANDIDATE IL-4 / IL-13 KINOID TO TREAT ALLERGIC ASTHMA
Download
2019/04/09 6:00PM
NEOVACS ANNOUNCES THE FULL RESULTS OF ITS PHASE IIb CLINICAL STUDY OF IFN KINOID IN LUPUS, PRESENTED AT THE 13th INTERNATIONAL LUPUS CONGRESS 2019
Download
2019/04/09 6:00PM
2019 Financial Calendar
Download
2019/04/09 6:00PM
IFN?-kinoid in systemic lupus erythematosus (SLE): results from a phase 2b, randomized, placebocontrolled study
Download
2019/04/01 6:00PM
NEOVACS ANNOUNCES AN AGREEMENT WITH BIOSYN GmbH TO DIVERSIFY ITS SUPPLY OF KEYHOLE LIMPET HEMOCYANIN (KLH)
Download
2019/03/27 6:00PM
NEOVACS STRENGTHENS ITS FINANCIAL STRUCTURE: ISSUANCE OF "ORNANE" FOR A MAXIMUM AMOUNT OF EUR 10M, WITHOUT STOCK SUBSCRIPTION WARRANTS
Download
2019/03/25 6:00PM
NEOVACS REPORTS FULL-YEAR 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
Download
2019/03/21 6:00PM
NEOVACS TO PRESENT THE PRECLINICAL RESULTS OF ITS THERAPEUTIC VACCINE CANDIDATE IL-4 / IL-13 KINOID AT KEYSTONE CONGRESS: "Origins of Allergic Disease: Microbial, Epithelial and Immune Interactions"
Download
2019/02/20 6:00PM
NEOVACS ANNOUNCES TWO APPOINTMENTS TO ITS EXECUTIVE COMMITTEE
Download
2019/02/05 6:00PM
NEOVACS TO HOST KOL MEETING TO DISCUSS ITS THERAPEUTIC VACCINE IFN KINOID FOR LUPUS TREATMENT
Download
2019/01/31 6:00PM
NEOVACS ANNOUNCES ITS CLINICAL ADVISORY BOARD MEETING TO DESIGN THE PHASE III STUDY FOR IFN-K IN LUPUS
Download
2019/01/24 6:00PM
NEOVACS TO PRESENT FULL RESULTS FROM THE PHASE IIb IFNA KINOID CLINICAL STUDY AT THE 13TH INTERNATIONAL LUPUS CONGRESS (LUPUS 2019)
Download
2019/01/08 6:00PM
NEOVACS SECURES FINANCING FROM THE ANR - THE FRENCH NATIONAL RESEARCH AGENCY - TO DEVELOP THE IL-4/IL-13 KINOID AS AN ALLERGY TREATMENT
Download


The publication history is accessible from the official French centralized storage mechanism regulated information www.info-financiere.fr.

Each PDF has been scanned by antimalware and incorporates a SECURITY MASTER Footprint. To check its authenticity:
www.security-master-footprint.com

Party powered automatically by Actusnews Wire ©
(Primary Information Provider)